Graviti Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?
GRAVITI PHARMS has seventeen approved drugs.
There is one tentative approval on GRAVITI PHARMS drugs.
Summary for Graviti Pharms
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 17 |
Drugs and US Patents for Graviti Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Graviti Pharms | ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED RELEASE;ORAL | 216349-001 | Jun 24, 2022 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Graviti Pharms | FENOFIBRIC ACID | choline fenofibrate | CAPSULE, DELAYED RELEASE;ORAL | 211626-002 | Jul 18, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Graviti Pharms | BACLOFEN | baclofen | TABLET;ORAL | 217788-001 | Jan 10, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Graviti Pharms | FUROSEMIDE | furosemide | TABLET;ORAL | 216629-003 | Oct 17, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
